NLRP3 and rheumatoid arthritis: In fact, release of particles in rheumatoid arthritis (pentaxin 3 and its ligand C1q), gout (uric acid crystals), and diabetes significantly over-activates NLRP3 inflammasome [230, 231], which contributes in development of these peripheral inflammatory diseases [232].